Technology | Computed Tomography (CT) | April 18, 2018

FDA Clears Siemens' Somatom go.All, go.Top CT Scanners

Latest additions to Somatom go. CT platform address advanced clinical fields and applications, including cardiology, CT-guided intervention and dual energy CT

FDA Clears Siemens' Somatom go.All, go.Top CT Scanners

April 18, 2018 — The U.S. Food and Drug Administration (FDA) has cleared the Somatom go.All and Somatom go.Top computed tomography (CT) systems from Siemens Healthineers. These additions to the company’s go. CT platform expand its concept of patient-centric mobile workflow, which is controlled via tablet and remote, into advanced clinical fields and applications such as cardiology, CT-guided intervention and dual energy CT.

With a 0.33-second rotation time, Stellar detector technology and a 75 kW generator, the 64-slice Somatom go.All meets a wide range of clinical needs. The 128-slice Somatom go.Top leverages the same technologies as well as a large detector to deliver an acquisition speed of up to 175 mm in one second, making it ideal for trauma scanning. Interventional procedures benefit from Guide&Go, what Siemens calls the first tablet-based solution for CT-guided interventions, which enables the interventional radiologist to use traditional touch features rather than a joystick for more precise image manipulation.

The new Athlon X-ray tube at the heart of both systems permits personalized dose optimization due to the tube’s ability to offer high mA at low kV. Users can adjust tube voltage in 10-kV increments while keeping tube current high. CARE kV technology removes the guesswork when adjusting dose parameters. An alternative to cumbersome injector mounting options, the gantry-mounted injector arm enables flexible arrangement of the contrast injector, making for a more organized working environment. Additionally, Somatom go.Top offers TwinBeam Dual Energy imaging for simultaneous examination of the same region at two different energy levels. Information from the resulting two image datasets is particularly beneficial in virtual non-contrast, gout, contrast enhancement, soft tissue differentiation, lesion characterization and oncology applications.

Each of the four scanners in the Somatom go. CT platform uses GO technologies such as Recon&GO to reduce the time a technologist spends on manual and repetitive reconstruction tasks. The platform enables zero-click reconstructions for even highly complex procedures such as coronary CT angiography and TwinBeam Dual Energy, helping the technologist remain close to – and focus on – patients.

For more information: www.usa.healthcare.siemens.com

 


Related Content

News | Cardiac Imaging

March 18, 2026 — Circle Cardiovascular Imaging (Circle CVI) has announced the expansion of its cvi42 cardiovascular ...

Home March 20, 2026
Home
News | Cardiac Imaging

March 19, 2026 — Heart disease is the leading cause of adult death worldwide, making cardiovascular disease diagnosis ...

Home March 20, 2026
Home
News | Cardiac Imaging

March 16, 2026 — The American Society for Preventive Cardiology (ASPC) will host its 2026 Virtual Imaging Symposium, a ...

Home March 17, 2026
Home
Feature | Cardiac Imaging

Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...

Home March 13, 2026
Home
News | Cardiac Imaging

March 6, 2026 — Building on its leadership in cardiac MR, Philips has received FDA 510(k) clearance for SmartHeart, an ...

Home March 09, 2026
Home
News | Cardiac Imaging

Feb. 26, 2026 — The U.S. Food and Drug Administration (FDA) has given 510(k) class II clearance of qXR-Detect, the ...

Home February 26, 2026
Home
News | Cardiac Imaging

Feb. 13, 2026 — Conavi Medical Corp. recently highlighted the publication of new peer-reviewed research titled “Deep ...

Home February 16, 2026
Home
News | Cardiac Imaging

Jan. 27. 2026 — Circle Cardiovascular Imaging Inc. has announced the release of cvi42 v6.4, the latest version of its ...

Home January 28, 2026
Home
News | Cardiac Imaging

Jan. 6, 2026 — UltraSight, a provider of AI-guided cardiac imaging workflows, has announced FDA clearance to expand its ...

Home January 16, 2026
Home
News | Cardiac Imaging

Jan. 12, 2026 — YorLabs, Inc., a medical technology company providing next-generation intracardiac imaging solutions for ...

Home January 13, 2026
Home
Subscribe Now